---
title: Risk Stratification Before Living Donor Kidney Transplantation in Patients
  With Preformed Donor-specific Antibodies by Different Crossmatch Methods
date: '2024-08-12'
linkTitle: https://pubmed.ncbi.nlm.nih.gov/39131238/?utm_source=curl&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&fc=20220326224207&ff=20240812184112&v=2.18.0.post9+e462414
source: heidelberg[Affiliation]
description: 'CONCLUSIONS: Especially FXM are useful for risk stratification, as the
  outcome of DSA-positive, FXM-negative patients is similar to that of DSA-negative
  patients, whereas FXM-positive patients have both more AMR and decreased 10yGS.
  Because of their lower sensitivity, the significance of Luminex-based crossmatches,
  C1qXM, and C3dXM would have to be examined in patients with stronger ...'
disable_comments: true
---
CONCLUSIONS: Especially FXM are useful for risk stratification, as the outcome of DSA-positive, FXM-negative patients is similar to that of DSA-negative patients, whereas FXM-positive patients have both more AMR and decreased 10yGS. Because of their lower sensitivity, the significance of Luminex-based crossmatches, C1qXM, and C3dXM would have to be examined in patients with stronger ...